Foamix Pharmaceuticals Ltd. Accumulated Other Comprehensive Income
Foamix Pharmaceuticals Ltd. had Accumulated Other Comprehensive Income of $5.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2020-03-12
- 2019-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.00K.
- 2019-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2019-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.00K.
- 2019-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2019-12-31 | $5.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$1.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$43.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$57.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$127.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$127.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$58.00K 10-K · filed 2019-02-28 |
| 2017-06-30 | -$4.00K 6-K · filed 2017-08-08 |
| 2016-12-31 | -$62.00K 10-K · filed 2018-03-01 |
| 2016-06-30 | $55.00K 6-K · filed 2016-08-10 |
| 2015-12-31 | -$130.00K 20-F · filed 2017-02-21 |
| 2015-06-30 | $64.00K 6-K · filed 2015-10-19 |
| 2014-12-31 | -$79.00K 20-F · filed 2016-03-02 |